SELLAS Life Sciences Group, Inc. (SLS)

4.56 -0.02 (-0.44%) USD  |  NASDAQ  |  Jan 22, 14:54
More

SELLAS Life Sciences Group Amortization Expense CF (Quarterly)

Amortization Expense CF (Quarterly) Chart

View Amortization Expense CF (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (Quarterly) Range, Past 5 Years

View Amortization Expense CF (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (Quarterly) Benchmarks

View Amortization Expense CF (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade